explore -WSS

explore

author：Wikipedia 2025-10-01 10:59:03 - browse：2727

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Physician executives need more than on

hotspot

WSS

FDA authorizes Novavax’s updated Covid

FDA early review: GLP

Chemotherapy drug shortage eases slightly but still widespread

Chan Zuckerberg Biohub Chicago to focus on inflammation

Ascension's ugly legal battle over care for poor patients in Texas

Nonprofit, backed by Microsoft, to certify AI tools in health care

focus

explore

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

VC firm General Catalyst wants to buy a health system

Jerome Adams on the need for new antivirals for Covid

Chemotherapy drug shortage eases slightly but still widespread

Psychedelics group wrestles with new pharma identity

Bristol 'take

Cancer drug shortages should be causing more outrage

The future of health care in the House

The cancer drug shortage isn’t new — and neither are the solutions

Gene therapy denied for Afghan refugee whose father aided U.S.

hotspot

Sana to lay off nearly a third of staff, de

When women are denied an abortion, their children fare worse than peers

Chan Zuckerberg Biohub Chicago to focus on inflammation

Does Paxlovid work in people vaccinated against Covid

JPM pitch from hospitals? Revenue streams outside of patient care

Sana to lay off nearly a third of staff, de

focus

hotspot

hotspot

hotspot